"43857-0193-1" National Drug Code (NDC)

Neurotox 30 mL in 1 BOTTLE, DROPPER (43857-0193-1)
(BioActive Nutritional, Inc.)

NDC Code43857-0193-1
Package Description30 mL in 1 BOTTLE, DROPPER (43857-0193-1)
Product NDC43857-0193
Product Type NameHUMAN OTC DRUG
Proprietary NameNeurotox
Non-Proprietary NameAgaricus Muscarius, Coccus Cacti, Conium Maculatum, Lycopodium Clavatum, Phosphorus, Gelsemium Sempervirens, Latrodectus Mactans, Rhus Toxicodendron, Tarentula Cubensis, Salmonalla Typhi, Clostridium Perfringens, Alluminum Metallicum, Antimonium Crudum, Artentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron Bromium, Cadmium Metallicum, Cerium Metallicum, Cesium Chloride, Chromium Metallicum, Cobaltum Metallicum, Cuprum Metallicum,
Dosage FormLIQUID
UsageORAL
Start Marketing Date20140725
End Marketing Date20181218
Marketing Category NameUNAPPROVED HOMEOPATHIC
ManufacturerBioActive Nutritional, Inc.
Substance NameAMANITA MUSCARIA FRUITING BODY; PROTORTONIA CACTI; CONIUM MACULATUM FLOWERING TOP; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; GELSEMIUM SEMPERVIRENS ROOT; LATRODECTUS MACTANS; TOXICODENDRON PUBESCENS LEAF; CITHARACANTHUS SPINICRUS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; CLOSTRIDIUM PERFRINGENS; ALUMINUM; ANTIMONY TRISULFIDE; SILVER; ARSENIC TRIOXIDE; GOLD; BARIUM CARBONATE; BERYLLIUM; BISMUTH; BORON; BROMINE; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; COBALT; COPPER; DYSPROSIUM; ERBIUM; EUROPIUM OXIDE; IRON; GADOLINIUM; GERMANIUM SESQUIOXIDE; HOLMIUM; IRIDIUM; LANTHANUM OXIDE; LITHIUM CARBONATE; MAGNESIUM; MANGANESE; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PLATINUM; LEAD; PRASEODYMIUM; RHODIUM; RUBIDIUM; SAMARIUM OXIDE; SELENIUM; TIN; STRONTIUM CARBONATE; TANTALUM; TERBIUM; THALLIUM; URANIUM; VANADIUM; YTTERBIUM OXIDE; ZINC; ASPARTAME; BENZALKONIUM CHLORIDE; FORMALDEHYDE; METHYLENE CHLORIDE; METHYLPARABEN; PROPYLPARABEN; SODIUM BENZOATE; SODIUM CITRATE; TITANIUM DIOXIDE; ZINC OXIDE; MEASLES VIRUS; INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/PERTH/16/2009 (H3N2) LIVE (ATTENUATED) ANTIGEN; INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED); HUMAN HERPESVIRUS 4; POLIOVIRUS; BOTULINUM TOXIN TYPE A; ESCHERICHIA COLI; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; YERSINIA ENTEROCOLITICA
Strength12; 12; 12; 12; 12; 30; 30; 30; 30; 33; 15; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30
Strength Unit[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/43857-0193-1